|
SEVERABLE FUNDING FOR NCI-FREDERICK
|
261200800001E
|
$248,730,791
|
$1,855
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
SWOG NCORP Research Base
|
5UG1CA189974-04
|
$4,459,372
|
|
BLANKE, CHARLES
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
CSHL Cancer Center Support Grant
|
5P30CA045508-30
|
$4,395,404
|
|
TUVESON, DAVID
|
COLD SPRING HARBOR LABORATORY
|
|
University of Rochester-NCORP Research Base
|
5UG1CA189961-04
|
$3,781,235
|
|
MORROW, GARY
|
UNIVERSITY OF ROCHESTER
|
|
COG NCORP Research Base
|
5UG1CA189955-04
|
$3,690,706
|
|
POLLOCK, BRAD
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
The VITamin D and OmegA-3 TriaL (VITAL)
|
5R01CA138962-09
|
$3,203,095
|
|
MANSON, JOANN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Integrative analysis of lung cancer etiology and risk
|
1U19CA203654-01A1
|
$2,833,706
|
|
AMOS, CHRISTOPHER
|
DARTMOUTH COLLEGE
|
|
Optimization of High Dose Conformal Therapy
|
5P01CA059827-19
|
$2,754,436
|
|
TEN HAKEN, RANDALL
|
UNIVERSITY OF MICHIGAN
|
|
Metro-Minnesota Community Clinical Oncology Program (MM-CCOP)
|
5UG1CA189863-05
|
$2,680,381
|
|
ANDERSON, DANIEL
|
HEALTHPARTNERS INSTITUTE
|
|
SPORE in Prostate Cancer
|
5P50CA186786-04
|
$2,380,000
|
|
CHINNAIYAN, ARUL
|
UNIVERSITY OF MICHIGAN
|
|
SPORE in Skin Cancer
|
5P50CA121973-10
|
$2,350,000
|
|
KIRKWOOD, JOHN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
RPCI-UPCI Ovarian Cancer SPORE
|
5P50CA159981-05
|
$2,300,000
|
|
ODUNSI, KUNLE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
SPORE University of Texas M.D. Anderson Cancer Center SPORE-Leukemia
|
5P50CA100632-15
|
$2,300,000
|
|
KANTARJIAN, HAGOP
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
The University of Texas Southwestern Medical Center SPORE in Kidney Cancer
|
5P50CA196516-02
|
$2,300,000
|
|
BRUGAROLAS, JAMES
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
SPORE in Skin Cancer
|
5P50CA174523-04
|
$2,300,000
|
|
HERLYN, MEENHARD
|
WISTAR INSTITUTE
|
|
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
|
5P50CA196530-03
|
$2,300,000
|
|
HERBST, ROY
|
YALE UNIVERSITY
|
|
SPORE: DF/HCC SPORE in GASTROINTESTINAL CANCER
|
5P50CA127003-10
|
$2,293,187
|
|
BASS, ADAM
|
DANA-FARBER CANCER INST
|
|
Integration of Clinical and Molecular Biomarkers for Melanoma Survival
|
1P01CA206980-01A1
|
$2,292,665
|
|
BERWICK, MARIANNE
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study
|
5U01CA195568-03
|
$2,248,270
|
|
CERHAN, JAMES
|
MAYO CLINIC ROCHESTER
|
|
Center for Multiple Myeloma Nanotherapy
|
5U54CA199092-03
|
$2,224,884
|
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
2U01CA164974-07
|
$2,195,369
|
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Washington University SPORE in Pancreatic Cancer
|
5P50CA196510-02
|
$2,143,077
|
|
HAWKINS, WILLIAM
|
WASHINGTON UNIVERSITY
|
|
MD Anderson Cancer Center Prostate Cancer SPORE
|
5P50CA140388-07
|
$2,100,013
|
|
LOGOTHETIS, CHRISTOPHER
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support (CORE) Grant
|
5P30CA034196-32
|
$2,100,000
|
|
LIU, EDISON
|
JACKSON LABORATORY
|
|
SPORE: Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer
|
5P50CA168504-05
|
$2,051,965
|
|
WINER, ERIC
|
DANA-FARBER CANCER INST
|
|
Normal and Neoplastic Growth in the Brain
|
5P01CA096832-13
|
$2,039,886
|
|
BAKER, SUZANNE
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Infrastructure for Pathways, a Prospective Study of Breast Cancer Survivorship
|
5U01CA195565-02
|
$2,033,770
|
|
KUSHI, LAWRENCE
|
KAISER FOUNDATION RESEARCH INSTITUTE
|
|
MOTILITY AND INVASION
|
5P01CA100324-15
|
$2,028,990
|
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Herpesviral Oncogenesis, Latency and Reactivation
|
5P01CA019014-38
|
$1,812,080
|
|
DAMANIA, BLOSSOM
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Integrated EGFR function in cytokine-driven inflammation and cancer
|
5P01CA062220-22
|
$1,805,475
|
|
STARK, GEORGE
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Maximizing Local Access to Therapeutic Deliveries in Glioblastoma
|
1P01CA207206-01A1
|
$1,793,324
|
|
DEBINSKI, WALDEMAR
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Pancreatic Cancer Detection Consortium
|
1U01CA210240-01A1
|
$1,761,905
|
|
HOLLINGSWORTH, MICHAEL
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
A Clinical Validation Center for Early Detection of Pancreatic Cancer
|
5U01CA200468-02
|
$1,759,344
|
|
MAITRA, ANIRBAN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Mechanisms of Esophageal Carcinogenesis
|
5P01CA098101-14
|
$1,607,533
|
|
RUSTGI, ANIL
|
UNIVERSITY OF PENNSYLVANIA
|
|
Tumor Hypoxia: Molecular Studies and Clinical Exploitation
|
5P01CA067166-20
|
$1,585,768
|
|
GIACCIA, AMATO
|
STANFORD UNIVERSITY
|
|
Validation of biomarkers for early diagnosis and risk prediction of pancreatic neoplasms
|
5U01CA200466-02
|
$1,537,769
|
|
BRAND, RANDALL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Multicenter Selective Lymphadenectomy Trial (MSLT II) in Melanoma
|
5R01CA189163-04
|
$1,507,063
|
|
FARIES, MARK
|
JOHN WAYNE CANCER INSTITUTE
|
|
Molecular Determinants of Cancer Therapeutic Response
|
5P01CA077852-18
|
$1,458,213
|
|
MONNAT, RAYMOND
|
UNIVERSITY OF WASHINGTON
|
|
Discovery of Anticancer Agents of Diverse Natural Origin
|
5P01CA125066-09
|
$1,405,544
|
|
KINGHORN, ALAN
|
OHIO STATE UNIVERSITY
|
|
The Role of the Microenvironment in Barrett's Esophagus
|
2U54CA163004-06
|
$1,310,083
|
|
WANG, TIMOTHY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Georgia NCI Community Oncology Research Program (NCORP)
|
5UG1CA189997-04
|
$1,304,055
|
|
CANTUARIA, GUILHERME
|
NORTHSIDE HOSPITAL ATLANTA
|
|
Risk and penetrance of mutations from breast cancer testing panels.
|
5R01CA192393-04
|
$1,263,145
|
|
COUCH, FERGUS
|
MAYO CLINIC ROCHESTER
|
|
MRI-guided focused ultrasound for drug delivery and ablation of brain tumors
|
5P01CA174645-05
|
$1,209,609
|
|
MCDANNOLD, NATHAN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
miRNA and colorectal cancer: associations with tumor phenotype and survival
|
5R01CA163683-06
|
$1,124,223
|
|
SLATTERY, MARTHA
|
UNIVERSITY OF UTAH
|
|
Development of Monoclonal Antibodies to Treat Pancreatic Cancer
|
5R44CA174025-03
|
$1,094,011
|
|
SUREBAN, SRIPATHI
|
COARE BIOTECHNOLOGY, INC.
|
|
Early Targets in Progression of Barrett's Esophagus to Esophageal Adenocarcinoma
|
2U54CA163059-06
|
$1,084,150
|
|
WANG, THOMAS
|
UNIVERSITY OF MICHIGAN
|
|
Molecular characterization of myeloma and related asymptomatic precursor states
|
5R01CA186646-04
|
$1,043,373
|
|
BROWN, ELIZABETH
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Etiological Studies of Gastric Carcinoma
|
5P01CA028842-32
|
$1,038,693
|
|
WILSON, KEITH
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Discovery of Risk Loci and Genomics of Pancreatic Cancer through Exome Sequencing
|
5R01CA181244-04
|
$1,028,501
|
|
SCHEET, PAUL
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Programmable Individualized NRT Merged With Digital Behavioral Support
|
2R44CA171786-04
|
$1,000,000
|
|
LEVY, ALAN
|
CHRONO THERAPEUTICS, INC.
|
Total relevant funding to Inflammatory Bowel Disease for this search: $1,490,892
|